LABORATORY CORPORATION OF AMERICA HOLDINGS

Laboratory Corporation of America Holdings

LH

US50540R4092

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 10:44:50 2024-04-26 am EDT			5-day change	1st Jan Change
198.6 ^USD	+0.11%		-1.27%	-12.48%

02:06pm	Truist Cuts Price Target on Laboratory Corp of America Holdings to $255 From $270, Keeps Buy Rating	MT
Apr. 25	Evercore ISI Cuts Laboratory Corp of America Holdings' Price Target to $210 From $225	MT

Laboratory Corporation of America Holdings(NYSE:LH) added to Russell 1000 Dynamic Index

June 24, 2022 at 12:00 am EDT

Latest news about Laboratory Corporation of America Holdings

Truist Cuts Price Target on Laboratory Corp of America Holdings to $255 From $270, Keeps Buy Rating	08:06am	MT
Evercore ISI Cuts Laboratory Corp of America Holdings' Price Target to $210 From $225	Apr. 25	MT
Leerink Partners Adjusts Laboratory Corp of America Price Target to $242 From $260, Keeps Outperform Rating	Apr. 25	MT
Laboratory Corp of America Q1 Adjusted Earnings, Revenue Increase; 2024 Adjusted EPS Outlook Updated	Apr. 25	MT
Transcript : Laboratory Corporation of America Holdings, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 Revenue $3.18B, vs. Street Est of $3.12B	Apr. 25	MT
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 EPS $3.68, vs. Street Est of $3.48	Apr. 25	MT
Laboratory Corporation of America Holdings Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Labcorp beats quarterly estimates on strong testing demand	Apr. 25	RE
North American Morning Briefing : More Tech -2-	Apr. 25	DJ
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	Apr. 24	RE
Laboratory Corporation of America Holdings Announces Winning Bid for Select Assets of Invitae	Apr. 24	CI
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million.	Apr. 23	CI
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation for approximately $240 million.	Apr. 23	CI
Labcorp Introduces Test for Early Detection of Neurodegenerative Diseases	Apr. 15	MT
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw	Apr. 15	CI
Labcorp Keeps Quarterly Dividend at $0.72 Per Share, Payable June 12 to Stockholders of Record May 28	Apr. 11	MT
Labcorp Declares Quarterly Dividend, Payable on June 12, 2024	Apr. 11	CI
Sector Update: Health Care Stocks Slump Wednesday Afternoon	Apr. 10	MT
Labcorp Says US FDA Granted Emergency Use Authorization for Mpox Home Collection Kit	Apr. 10	MT
Labcorp Gets Emergency Authorization from FDA for Home Kit to Detect Monkeypox	Apr. 10	DJ
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit	Apr. 10	CI
Laboratory Corp of America Expands Precision Oncology Portfolio	Apr. 08	MT
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs	Apr. 08	CI
Labcorp Launches Labcorp Plasma Detect? Extending Leadership into Molecular Residual Disease Clinical Research	Apr. 05	CI

Chart Laboratory Corporation of America Holdings

Duration

Period

Chart Laboratory Corporation of America Holdings

More charts

Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).

Sector

Healthcare Facilities & Services

Calendar

2024-05-14 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Laboratory Corporation of America Holdings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

198.4 USD

Average target price

240.9 USD

Spread / Average Target

+21.47%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.48%	16.72B
CVS HEALTH CORPORATION	-15.13%	84.87B
HCA HEALTHCARE, INC.	+11.18%	83.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.4B
FRESENIUS SE & CO. KGAA	-2.42%	16.4B
QUEST DIAGNOSTICS INCORPORATED	-1.71%	15.04B
EUROFINS SCIENTIFIC SE	-4.07%	11.88B
FRESENIUS MEDICAL CARE AG	-1.24%	11.88B
PURE HEALTH HOLDING	-31.75%	11.86B
DAVITA INC.	+25.54%	11.64B

Other Healthcare Facilities & Services